Found 21 matching trials
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) N/A An observational time and motion study in a clinical oncology setting is ut...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR PHASE4 The purpose of this study is to assess the efficacy, safety and patient acc...
Show More Location
Westmead Hospital
Learn More & Join Trial
Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects PHASE4 The purpose of the study is to assess the efficacy of an extended injection...
Show More Location
Universidade Federal do Rio de Janeiro - Department of Internal Medicine - Section of Endocrinology - Neuroendocrine Research Center
Learn More & Join Trial
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma PHASE2 The hepatocellular carcinoma (HCC) represents more than 5% of all human mal...
Show More Location
D. Cotugno Hospital
Learn More & Join Trial
Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly PHASE1 The objectives of the protocol is to determine the maximum tolerated dose a...
Show More Location
Antwerp University Hospital
Learn More & Join Trial
Circulating Tumor Cells and Tumor DNA in HCC and NET N/A Background Treatment and control of cancer is associated with high costs, t...
Show More Location
Department of Hepatology and Gastroenterology
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients PHASE4 The SAUNA trial is a multi-national, multi-centre, open-label, randomised, ...
Show More Learn More & Join Trial
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide PHASE4 This study is being done to evaluate differences in patient experience duri...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Acromegaly Combination Treatment Study NA In this study the investigators will evaluate whether combination low dose ...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial